Human Bone Marrow CD133+ Stem/Progenitor Cells
Human Bone Marrow CD133+ Stem/Progenitor Cells from Ace Therapeutics are isolated using positive immunomagnetic cell separation procedures from bone marrow.
Capable of a high level of proliferation and a wide range of differentiation, transplantation of bone marrow CD133+ cell lines has been shown to not only induced multilineage human hematopoiesis through the CD34+ lineage but also induce regeneration of cell lines in vitro in multiple locations by differentiating into endothelial cells, neural cells, hepatocytes, osteoblasts, and myocytes, with the list of tissue types this cell can differentiate into gradually increasing.
Capable of a high level of proliferation and a wide range of differentiation, transplantation of bone marrow CD133+ cell lines has been shown to not only induced multilineage human hematopoiesis through the CD34+ lineage but also induce regeneration of cell lines in vitro in multiple locations by differentiating into endothelial cells, neural cells, hepatocytes, osteoblasts, and myocytes, with the list of tissue types this cell can differentiate into gradually increasing.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | BBM-C-174 |
| Pricing | Inquiry |
| Product Category | Stem Cells |
| Species | Human |
| Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
| Source | Bone Marrow |
| Recommended Medium | It is recommended to use Human Bone Marrow CD133+ Stem/Progenitor Cells Medium Kit for culturing in vitro. |
| Cell Type | Stem Cell |
| Disease | Normal |
| Quality Control | Human Bone Marrow CD133+ Stem/Progenitor Cells test negative for bacteria, yeast, fungi, and mycoplasma. |
| Shipping and Storage |
|